Skip to main content

Table 2 Clinical features and outcomes of patients

From: Clinicopathological features and surgical outcomes of neuroendocrine tumors of ampulla of Vater

Case Sex Age range Symptom L/N
ratio
Biopsy
result
Operation Adjuvant CTx Recurrence site Treatment
for recurrence
Survival outcome
1 Female 50–59 Incidental 62.1% NET PPPD Yes NED   78 months
alive
2 Male 60–69 Jaundice 15.8% NET PPPD Yes Liver RFA, CTx 67 months
dead
3 Female 50–59 Incidental 40.9% NET PPPD Yes NED   45 months
alive
4 Male 30–39 Incidental 52.7% NET PD Yes NED   44 months
alive
5 Male 60–69 Incidental 23.4% NET PD No liver CTx 43 months
alive
  1. CTx chemotherapy, L/N ratio lymphocyte/neutrophil ratio, NED no evidence of disease, NET neuroendocrine tumor, PD pancreaticoduodenectomy, PPPD pylorus preserving pancreaticoduodenectomy, RFA radiofrequency ablation